Therapeutic abortion in Iran: an epidemiologic study of legal abortion in 2 years.
Abortion, Legal
/ statistics & numerical data
Abortion, Therapeutic
/ legislation & jurisprudence
Adolescent
Adult
Chromosome Aberrations
/ statistics & numerical data
Congenital Abnormalities
/ epidemiology
Female
Humans
Iran
/ epidemiology
Pregnancy
Pregnancy Complications
/ epidemiology
Young Adult
Fetal anomaly
Legal abortion
Maternal disease
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
27 May 2020
27 May 2020
Historique:
received:
10
04
2020
accepted:
19
05
2020
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
5
3
2021
Statut:
epublish
Résumé
Unsafe abortion is one of the most important causes of death and disability among mothers in countries where abortion is illegal. These conditions have changed since then. The present study has investigated the cases who were referred to the legal medicine organization to receive abortion permission. This country level secondary patient data analysis, investigated all the cases who were referred to the legal medicine centers of Iran for abortion permission during 2015 to 2017. From 21,477 applicants, 15,617 (72.71%) received permission including 14,367 (91.99%) for fetal abnormalities and 1250 (8.01%) for maternal diseases. The most common fetal abnormalities/disorders were nervous system malformations (26.4%), chromosomal abnormalities (18.4%) and of maternal diseases were circulatory system diseases (43.9%), neoplasms (13.4%) and genitourinary system diseases (9.9%). The most common reasons for not permission were lack of supplementary documents to prove (38.8%), not competency with the criteria (33.9%), and gestational age of more than 19 weeks (25.8%).
Identifiants
pubmed: 32460874
doi: 10.1186/s13104-020-05098-y
pii: 10.1186/s13104-020-05098-y
pmc: PMC7254741
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
261Subventions
Organisme : Legal Medicine Research Center ILMO
ID : 73/M
Références
Reprod Health. 2018 Nov 21;15(1):190
pubmed: 30463567
Iran Red Crescent Med J. 2014 Oct 05;16(10):e15765
pubmed: 25558379
Int Perspect Sex Reprod Health. 2016 Jun 1;42(2):93-101
pubmed: 28825910
Lancet. 2016 Jul 16;388(10041):258-67
pubmed: 27179755
Arch Iran Med. 2017 May;20(5):282-287
pubmed: 28510463
J Adv Nurs. 2012 Jun;68(6):1247-55
pubmed: 21851383
Womens Health Issues. 2019 Sep - Oct;29(5):364-369
pubmed: 31387774
BMC Res Notes. 2019 Sep 13;12(1):574
pubmed: 31519224
Arch Iran Med. 2013 Oct;16(10):594-8
pubmed: 24093141
Int Perspect Sex Reprod Health. 2018 Jun 1;44(2):73-79
pubmed: 30475213
Curr Opin Obstet Gynecol. 2016 Dec;28(6):517-521
pubmed: 27805969
J Med Ethics. 2006 Nov;32(11):652-7
pubmed: 17074823
BMC Womens Health. 2019 Jan 5;19(1):1
pubmed: 30611257
Prenat Diagn. 2015 Nov;35(11):1128-36
pubmed: 26223365
Lancet. 2017 Nov 25;390(10110):2372-2381
pubmed: 28964589
Am J Public Health. 2013 Apr;103(4):585-9
pubmed: 23409915
Reprod Health. 2016 Apr 27;13:48
pubmed: 27117480
East Mediterr Health J. 2019 Jan 23;24(11):1040-1048
pubmed: 30701518
Womens Health Issues. 2018 Jul - Aug;28(4):287-288
pubmed: 29622285
Reprod Health. 2005 Nov 15;2:10
pubmed: 16288647
Lancet Public Health. 2017 Nov;2(11):e493-e500
pubmed: 29253373
Int Fam Plan Perspect. 2008 Mar;34(1):40-50
pubmed: 18440916
Hum Reprod. 2017 Jun 1;32(6):1160-1169
pubmed: 28402552
East Mediterr Health J. 2008 Jan-Feb;14(1):103-9
pubmed: 18557457
Contraception. 2010 Feb;81(2):93-6
pubmed: 20103443
J Obstet Gynaecol Can. 2009 Dec;31(12):1149-58
pubmed: 20085681